UBS raised the firm’s price target on Crowdstrike to $385 from $300 and keeps a Buy rating on the shares. The firms remains positive on Crowdstrike into Q4 earnings, and says checks continue to skew very positive, the analyst tells investors in a research note. While UBS likes the momentum Crowdstrike has with newer products and new routes to market, it acknowledges that expectations are high.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on CRWD: